Conmed (CNMD) Tops Q1 EPS by 3c; Raises Outlook
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $33.06 -2.33%
EPS Growth %: -5.2%
Financial Fact:
Weighted average common shares Diluted: 27.95M
Today's EPS Names:
CRMT, REPL, HURC, More
EPS Growth %: -5.2%
Financial Fact:
Weighted average common shares Diluted: 27.95M
Today's EPS Names:
CRMT, REPL, HURC, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.57, $0.03 better than the analyst estimate of $0.54. Revenue for the quarter came in at $218.4 million versus the consensus estimate of $212.99 million.
GUIDANCE:
Conmed sees FY2019 EPS of $2.47-$2.52, from $2.42-$2.47 and the consensus of $2.45.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Veeva Systems (VEEV) Tops Q1 EPS by 10c, Offers Guidance
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
